The hCMEC/D3 cell line as a model of the human blood brain barrier

Fluids and Barriers of the CNS

Volumn 10, Issue 1, 2013, Pages

  Weksler, Babette ^a   Romero, Ignacio A ^b   Couraud, Pierre Olivier ^c,d,e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b OPEN UNIVERSITY   (United Kingdom)

^c INSTITUT COCHIN   (France)

^d CNRS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Blood brain barrier; Brain endothelium; Immortalized cell line; In vitro model

Indexed keywords

ABC TRANSPORTER; AMANTADINE; ANTIRETROVIRUS AGENT; ATAZANAVIR; BETA CATENIN; BREAST CANCER RESISTANCE PROTEIN; CD31 ANTIGEN; CD34 ANTIGEN; CD40 ANTIGEN; CLAUDIN 5; CYTOTOXIC AGENT; DIOXIN; ENDOGLIN; JUNCTIONAL ADHESION MOLECULE A; MANNITOL; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; NIFURTIMOX; OCCLUDIN; PROTEIN ZO1; PROTEIN ZO2; RIMANTADINE; RITONAVIR; TELOMERASE REVERSE TRANSCRIPTASE; UNINDEXED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR; WNT PROTEIN;

BACTERIAL STRAIN; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CELL JUNCTION; CELL LINE; CELL TYPE; CENTRAL NERVOUS SYSTEM; CEREBRAL MICROVESSEL ENDOTHELIAL CELL; CRYPTOCOCCUS; CYTOLOGY; CYTOTOXICITY; DEGENERATIVE DISEASE; DERIVATIZATION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TRANSPORT; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; HOST PATHOGEN INTERACTION; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MEDIATOR; NEISSERIA MENINGITIDIS; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEOMICS; RETROVIRUS; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; TRANSENDOTHELIAL ELECTRICAL RESISTANCE; UMBILICAL VEIN ENDOTHELIAL CELL; VIRUS STRAIN;

EID: 84876161205     PISSN: None     EISSN: 20458118     Source Type: Journal    
DOI: 10.1186/2045-8118-10-16     Document Type: Review

References (76)

1. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005, 19:1872-1874.
2. Mkrtchyan H, Scheler S, Klein I, Fahr A, Couraud PO, Romero IA, Weksler BB, Liehr T. Molecular cytogenetic characterization of the human cerebral microvessel endothelial cell line hCMEC/D3. Cytogenet Genome Res 2009, 126:313-317. 10.1159/000253080, 19864871.
3. Afonso PV, Ozden S, Cumont MC, Seilhean D, Cartier L, Rezaie P, Mason S, Lambert S, Huerre M, Gessain A, Couraud PO, Pique C, Ceccaldi PE, Romero IA. Alteration of blood-brain barrier integrity by retroviral infection. PLoS Pathog 2008, 14:e1000205.
4. Luissint AC, Federici C, Guillonneau F, Chrétien F, Camoin L, Glacial F, Ganeshamoorthy K, Couraud PO. Guanine nucleotide-binding protein Gαi2: a new partner of claudin-5 that regulates tight junction integrity in human brain endothelial cells. J Cereb Blood Flow Metab 2012, 32:860-873. 10.1038/jcbfm.2011.202, 22333621.
5. Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, Reis M, Felici A, Wolburg H, Fruttiger M, Taketo MM, von Melchner H, Plate KH, Gerhardt H, Dejana E. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol 2008, 183:409-417. 10.1083/jcb.200806024, 2575783, 18955553.
6. Cristante E, McArthur S, Mauro C, Maggioli E, Romero IA, Wylezinska-Arridge M, Couraud PO, Lopez-Tremoleda J, Christian HC, Weksler BB, Malaspina A, Solito E. Identification of an essential endogenous regulator of blood brain barrier integrity: pathological and therapeutic implications. Proc Natl Acad Sci USA 2013, 110:832-841. 10.1073/pnas.1209362110, 23277546.
7. Urich E, Lazic SE, Molnos J, Wells I, Freskgard PO. Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models. PLoS One 2012, 7:e38149. 10.1371/journal.pone.0038149, 3364980, 22675443.
8. Poller B, Guttmann H, Krahlenbuhl S, Weksler BB, Romero IA, Couraud PO, Tuffin G, Drewe J, Huwyler J. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. J Neurochem 2008, 107:1358-1368. 10.1111/j.1471-4159.2008.05730.x, 19013850.
9. Cucullo L, Couraud PO, Weksler BB, Romero IA, Hossain M, Rapp E, Janigro D. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J Cereb Blood Flow Metab 2008, 28:312-328. 10.1038/sj.jcbfm.9600525, 17609686.
10. Cowan SKM, Easton AS. Neutrophils block permeability increases induced by oxygen glucose deprivation in a culture model of the human blood-brain barrier. Brain Res 2010, 1332:20-31.
11. Lopez-Ramirez MA, Fischer R, Torres-Badillo CC, Davies HA, Logan K, Pfizenmaier K, Male DK, Sharrack B, Romero IA. Role of caspases in cytokine-induced barrier breakdown in human brain endothelial cells. J Immunol 2012, 189:3130-3139. 10.4049/jimmunol.1103460, 22896632.
12. Förster C, Burek M, Romero IA, Weksler BB, Couraud PO, Drenckhahn D. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J Physiol 2008, 586:1937-1949. 10.1113/jphysiol.2007.146852, 2375735, 18258663.
13. Haarmann A, Deiss A, Prochaska J, Foerch C, Weksler BB, Romero IA, Couraud PO, Stoll G, Rieckmann P, Buttmann M. Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown. PLoS One 2010, 5:e13568. 10.1371/journal.pone.0013568, 2958838, 21060661.
14. Roberts TK, Eugenin EA, Lopez L, Romero IA, Weksler BB, Couraud PO, Berman JW. CCL2 disrupts the adherens junction: implications for neuroinflammation. Lab Invest 2012, 92:1213-1233. 10.1038/labinvest.2012.80, 3409314, 22641100.
15. Luissint AC, Artus C, Glacial F, Ganeshamoorthy K, Couraud PO. Tight junctions of the blood-brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS 2012, 9:23. 10.1186/2045-8118-9-23, 3542074, 23140302.
16. Butt AM, Jones HC, Abbott NJ. Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J Physiol 1990, 429:47-62. 1181686, 2277354.
17. Hatherell K, Couraud PO, Romero IA, Weksler BB, Pilkington GJ. Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co- and tri-Transwell cultivation methods. J Neurosci Meth 2011, 199:223-229.
18. Dauchy S, Miller F, Couraud PO, Weaver RJ, Weksler BB, Romero IA, Scherrmann JM, De Waziers I, Decleves X. Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem Pharm 2009, 77:897-909. 10.1016/j.bcp.2008.11.001, 19041851.
19. Ohtsuki S, Ikeda C, Uchida Y, Sakamoto Y, Miller F, Glacial F, Decleves X, Scherrmann JM, Couraud PO, Kubo Y, Tachikawa M, Terasaki T. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model. Mol Pharm 2012, 10:289-296.
20. Tai LM, Reddy PS, Lopez-Ramirez MA, Davies HA, Male DK, Loughlin AJ, Romero IA. Polarized P-glycoprotein expression by the immortalized human brain endothelial cell line, hCMEC/D3, restricts apical-to-basal permeability to rhodamine 123. Brain Res 2009, 1292:14-24.
21. Poller B, Drewe J, Krahlenbuhl S, Huwyler J, Guttman H. Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier. Cell Mol Neurobiol 2010, 30:63-70. 10.1007/s10571-009-9431-1, 19629677.
22. Male DK. Expression and induction of P-glycoprotein-1 on cultured human brain endothelium. J Cereb Blood Flow Metab 2009, 29:1760-1763. 10.1038/jcbfm.2009.101, 19638996.
23. Zastre JA, Chan GN, Ronaldson PT, Ramaswamy M, Couraud PO, Romero IA, Weksler B, Bendayan M, Bendayan R. Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line. J Neurosci Res 2009, 87:1023-1036. 10.1002/jnr.21898, 18855943.
24. Zhong Y, Hennig B, Toborek M. Intact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cells. J Cereb Blood Flow Metab 2010, 30:522-533. 10.1038/jcbfm.2009.214, 2949153, 19794400.
25. Hoque MT, Robillard KR, Bendayan R. Regulation of breast cancer resistance protein by peroxisome proliferator-activated receptor α in human brain microvessel endothelial cells. Mol Pharmacol 2012, 81:598-609. 10.1124/mol.111.076745, 22266374.
26. Watson CP, Dogruel M, Mihoreanu L, Begley DJ, Weksler BB, Couraud PO, Romero IA, Thomas SA. The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of the human blood-brain barrier: evidence for involvement of breast cancer resistance protein. Brain Res 2012, 1436:111-121. 3281990, 22200378.
27. Dickens D, Owen A, Alfirevic A, Giannoudis A, Davies A, Weksler B, Romero IA, Couraud PO, Pimohamed M. Lamotrigine is a substrate for OCT-1 in brain endothelial cells. Biochem Pharm 2012, 83:805-814. 10.1016/j.bcp.2011.12.032, 22227272.
28. Kooijmans SA, Senyschyn D, Mezhiselvam MM, Morizzi J, Charman SA, Weksler B, Romero IA, Couraud PO, Nicolazzo JA. The involvement of a Na+ and Cl- -dependent transporter in the brain uptake of amantadine and rimantadine. Mol Pharm 2012, 9:883-893. 10.1021/mp2004127, 22352408.
29. Carl SM, Lindley DJ, Couraud PO, Weksler BB, Romero I, Mowery SA, Knipp GT. ABC and SLC Transporter expression and Proton Oligopeptide Transporter (POT) mediated permeation across the human blood-brain barrier cell line, hCMEC/D3. Mol Pharm 2010, 7:1057-1068. 10.1021/mp900178j, 2914114, 20524699.
30. el-Bacha RS, Minn A. Drug metabolizing enzymes in cerebrovascular endothelial cells afford a metabolic protection to the brain. Cell Mol Biol 1999, 45:15-23.
31. Dauchy S, Dutheil F, Weaver RJ, Chassoux F, Daumas-Duport C, Couraud PO, Scherrmann JM, De Waziers I, Declèves X. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 2008, 107:1518-1528. 10.1111/j.1471-4159.2008.05720.x, 19094056.
32. Chattopadhyay N, Zastre J, Wong HL, Wu XY, Bendayan R. Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atanazavir, by a human brain endothelial cell line. Pharm Res 2008, 25:2262-2271. 10.1007/s11095-008-9615-2, 18516666.
33. Markoutsa E, Pampalakis G, Niarakis A, Romero IA, Weksler BB, Couraud PO, Antimisiaris SG. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line. Europ J Pharmaceut Biopharmaceut 2011, 77:263-274.
34. Pinzón-Daza M, Garzón R, Couraud PO, Romero IA, Weksler BB, Ghigo D, Bosia A, Riganti C. The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increases in vitro drug delivery across blood-brain barrier cells. Br J Pharmacol 2012, 167:1431-1447. 10.1111/j.1476-5381.2012.02103.x, 22788770.
35. Freese C, Uboldi C, Gibson MI, Unger RE, Weksler BB, Romero IA, Couraud PO, Kirkpatrick CJ. Uptake and cytotoxicity of citrate-coated gold nanospheres: comparative studies on human endothelial and epithelial cells. Part Fibre Toxicol 2012, 3:9-23.
36. Li T, Bourgeois JP, Celli S, Glacial F, LeSourd AM, Mecheri S, Weksler BB, Romero IA, Couraud PO, Rougeon F, Lafaye P. Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: application to brain imaging. FASEB J 2012, 26:3969-3979. 10.1096/fj.11-201384, 22730440.
37. Lopez-Ramirez MA, Fischer R, Torres-Badillo CC, Davies HA, Logan K, Pfizenmaier K, Male DK, Sharrack B, Romero IA. Role of caspases in cytokine-induced barrier breakdown in human brain endothelial cells. J Immunol 2012, 189:3130-3139. 10.4049/jimmunol.1103460, 22896632.
38. Fasler-Kan E, Suenderhauf C, Barteneva N, Poller B, Gygax D, Huwyler J. Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3. Brain Res 2010, 1354:15-22.
39. Subileau EA, Rezaie P, Davies HA, Colyer FM, Greenwood J, Male DK, Romero IA. Expression of chemokines and their receptors by human brain endothelium: implications for multiple sclerosis. J Neuropathol Exp Neurol 2009, 68:227-240. 10.1097/NEN.0b013e318197eca7, 19225413.
40. Hurst LA, Bunning RA, Couraud PO, Romero IA, Weksler BB, Sharrack B, Woodroofe MN. Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. J Neuroimmunol 2009, 210:108-112. 10.1016/j.jneuroim.2009.02.008, 19324423.
41. Reijerkerk A, Kooij G, van der Pol SM, Leyen T, van Het Hof B, Couraud PO, Vivien D, Dijkstra CD, de Vries HE. Tissue-type plasminogen activator is a regulator of monocyte diapedesis through the brain endothelial barrier. J Immunol 2008, 181:3567-3574.
42. van Doorn R, Lopes Pinheiro MA, Kooij G, Lakeman K, van Het Hof B, van der Pol SM, Geerts D, van Horssen J, van der Valk P, van der Kam E, Ronken E, Reijerkerk A, de Vries HE. Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier. J Neuroinflammation 2012, 9:133. 10.1186/1742-2094-9-133, 3425155, 22715976.
43. Viegas P, Chaverot N, Enslen H, Perrière N, Couraud PO, Cazaubon S. Junctional expression of the prion protein PrPc by brain endothelial cells: a role in trans-endothelial migration of human monocytes. J Cell Sci 2006, 119:4634-4643. 10.1242/jcs.03222, 17062642.
44. Bahbouhi B, Berthelot L, Pettre S, Michel L, Wiertlewski S, Weksler BB, Romero IA, Miller F, Couraud PO, Brouard S, Laplaud DA, Soulillou JP. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line. J Leukocyte Biol 2008, 86:1049-1059.
45. Joice SL, Mydeen F, Couraud PO, Weksler BB, Romero IA, Fraser PA, Easton AS. Modulation of blood-brain barrier permeability by neutrophils: in vitro and in vivo studies. Brain Res 2009, 1298:13-23.
46. Afonso PV, Ozden S, Prevost MC, Schmitt C, Seilhean D, Weksler B, Couraud PO, Gessain A, Romero IA, Ceccaldi PE. Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosine light chain kinase in endothelial tight-junction disorganization. J Immunol 2007, 179:2576-2583.
47. András IE, Toborek M. HIV-1-induced alterations of claudin-5 expression at the blood-brain barrier level. Meth Mol Biol 2011, 762:355-370.
48. Zhong Y, Zhang B, Eum SY, Toborek M. HIV-1 Tat triggers nuclear localization of ZO-1 via Rho signaling and cAMP response element-binding protein activation. J Neurosci 2012, 32:143-150. 10.1523/JNEUROSCI.4266-11.2012, 3566645, 22219277.
49. Andras JE, Rha G, Huang W, Eum S, Couraud PO, Romero IA, Hennig B, Toborek M. Simvastatin protects against amyloid beta and HIV-1 Tat-induced promoter activities of inflammatory genes in brain endothelial cells. Mol Pharmacol 2008, 273:1424-1433.
50. Huang W, Rha GB, Han MJ, Eum SY, András IE, Zhong Y, Hennig B, Toborek M. PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells. J Neurochem 2008, 107:497-509. 10.1111/j.1471-4159.2008.05626.x, 2597373, 18710415.
51. Huang W, Eum SY, András IE, Hennig B, Toborek M. PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J 2009, 23:1596-1606. 10.1096/fj.08-121624, 2669424, 19141539.
52. Huang W, Rha GB, Chen L, Seelbach MJ, Zhang B, András IE, Bruemmer D, Hennig B, Toborek M. Inhibition of telomerase activity alters tight junction protein expression and induces transendothelial migration of HIV-1-infected cells. Am J Physiol Heart Circ Physiol 2010, 298:1136-1145.
53. Andras IE, Eum SY, Huang W, Zhong Y, Hennig B, Toborek M. HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin. Mol Cell Neurosci 2010, 43:232-234. 10.1016/j.mcn.2009.11.004, 2818553, 19944163.
54. Zhong Y, Smart EJ, Weksler BB, Coutraud PO, Hennig B, Toborek M. Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J Neurosci 2008, 28:7788-7796. 10.1523/JNEUROSCI.0061-08.2008, 2635104, 18667611.
55. András IE, Eum SY, Toborek M. Lipid rafts and functional caveolae regulate HIV-induced amyloid beta accumulation in brain endothelial cells. Biochem Biophys Res Commun 2012, 421:177-183. 10.1016/j.bbrc.2012.03.128, 22490665.
56. Vu K, Weksler BB, Romero IA, Couraud PO, Gelli A. Immortalized human brain endothelial cell line hCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans. Eukaryot Cell 2009, 8:1803-1811. 10.1128/EC.00240-09, 2772405, 19767445.
57. Coureuil M, Mikaty G, Miller F, Lecuyer H, Bernard S, Bourdoulous S, Dumenil G, Mege RM, Weksler BB, Romero IA, Couraud PO, Nassif X. Meningococcal type IV pili recruit the polarity complex to cross the brain endothelium. Science 2009, 325:83-87. 10.1126/science.1173196, 19520910.
58. Coureuil M, Lécuyer H, Scott MG, Boularan C, Enslen H, Soyer M, Mikaty G, Bourdoulous S, Nassif X, Marullo S. Meningococcus hijacks a β2-adrenoceptor/β-Arrestin pathway to cross brain microvasculature endothelium. Cell 2010, 143:1149-1160. 10.1016/j.cell.2010.11.035, 21183077.
59. Lécuyer H, Nassif X, Coureuil M. Two strikingly different signaling pathways are induced by meningococcal type IV pili on endothelial and epithelial cells. Infect Immun 2012, 80:175-186. 10.1128/IAI.05837-11, 3255667, 22064711.
60. Jambou R, Combes V, Jambou MJ, Weksler BB, Couraud PO, Grau GE. Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions. PLoS Pathog 2010, 6:e1001021. 10.1371/journal.ppat.1001021, 2912387, 20686652.
61. Zougbede S, Miller F, Ravassard P, Rebollo A, Cicron L, Couraud PO, Mazier D, Moreno A. Metabolic acidosis induced by Plasmodium falciparum intraerythrocytic stages alters blood-brain barrier integrity. J Cereb Blood Flow Metab 2011, 31:514-526. 10.1038/jcbfm.2010.121, 3049507, 20683453.
62. Tai LM, Holloway KA, Male DK, Loughlin AJ, Romero IA. Amyloid-beta-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J Cell Mol Med 2010, 14:1101-1112.
63. Kania KD, Wijesuriya HC, Hladky SB, Barrand MA. Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells. Brain Res 2011, 1418:1-11.
64. Fossati S, Cam J, Mezhericher E, Romero IA, Couraud PO, Weksler BB, Ghiso J, Rostagno A. Differential activation of mitochondrial apoptotic pathways by vasculotropic amyloid beta variants in cells composing thee cerebral vessel walls. FASEB J 2010, 24:229-241. 10.1096/fj.09-139584, 2797039, 19770225.
65. Hernandez-Guillamon M, Mawhirt S, Fossati S, Blais S, Pares M, Penalba A, Boada M, Couraud PO, Neubert TA, Montaner J, Ghiso J, Rostagno A. Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells. J Biol Chem 2010, 285:27144-27158. 10.1074/jbc.M110.135228, 2930713, 20576603.
66. Tai LM, Loughlin AJ, Male DK, Romero IA. P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta. J Cereb Blood Flow Metab 2009, 29:1079-1083. 10.1038/jcbfm.2009.42, 19367293.
67. Candela P, Gosselet F, Saint-Pol J, Sevin E, Boucau MC, Boulanger E, Cecchelli R, Fenart L. Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein. J Alzheimers Dis 2010, 22:849-859.
68. Prudhomme JG, Sherman IW, Land KM, Moses AV, Stenglein S, Nelson JA. Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells. Int J Parasitol 1996, 26:647-655. 10.1016/0020-7519(96)00027-6, 8875310.
69. Kusch-Poddar M, Drewe J, Fux I, Gutmann H. Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood-brain barrier. Brain Res 2005, 1064:21-31. 10.1016/j.brainres.2005.10.014, 16289483.
70. Kannan R, Chakrabarti R, Tang D, Kim KJ, Kaplowitz N. GSH transport in human cerebrovascular endothelial cells and human astrocytes: evidence for luminal localization of Na+-dependent GSH transport in HCEC. Brain Res 2000, 852:374-382. 10.1016/S0006-8993(99)02184-8, 10678765.
71. Wassmer SC, Combes V, Candal FJ, Juhan-Vague I, Grau GE. Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect Immun 2006, 74:645-653. 10.1128/IAI.74.1.645-653.2006, 1346683, 16369021.
72. Ketabi-Kiyanvash N, Herold-Mende C, Kashfi F, Caldeira S, Tommasino M, Haefeli WE, Weiss J. NKIM-6, a new immortalized human brain capillary endothelial cell line with conserved endothelial characteristics. Cell Tissue Res 2007, 328:319-329.
73. Chaitanya GV, Cromer WE, Wells SR, Jennings MH, Couraud PO, Romero IA, Weksler BB, Erdreich-Epstein A, Mathis HM, Minagar A, Alexander S. Gliovascular and cytokine interactions moderate brain endothelial barrier in vitro. J Neuroinflammation 2009, 8:162.
74. Sano Y, Shimizu F, Abe M, Maeda T, Kashiwamura Y, Ohtsuki S, Terasaki T, Obinala M, Kaijwara K, Fujii M, Suzuki M, Kanda T. Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood-brain barrier function. J Cell Physiol 2010, 225:519-528. 10.1002/jcp.22232, 20458752.
75. Kamiichi A, Furihata T, Kishida S, Ohta Y, Saito K, Kawamatsu S, Chiba K. Establishment of a new conditionally immortalized cell line from human brain microvascular endothelial cells: a promising tool for human blood-brain barrier studies. Brain Res 2012, 1488:113-122.
76. Lippmann ES, Azarin SM, Kay JE, Nessler RA, Wilson HK, Al-Ahmad A, Palecek SP, Shusta EV. Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat Biotech 2012, 30:783-791.